Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease portal vein thrombosis
Comorbidity |portal vein thrombosis
Sentences 69
PubMedID- 25810714 Recent evidence suggests the potential relationship of the survival with the occurrence of portal vein thrombosis (pvt) in liver cirrhosis [10].
PubMedID- 25884197 One nmld cohort patient with hcv cirrhosis (hep 25) was found to have a liver mass with adjacent portal vein thrombosis on a surveillance ultrasound after enrollment and was excluded based upon a suspected new diagnosis of hcc, resulting in 9 eligible patients in the nmld cohort.
PubMedID- 22540056 portal vein thrombosis occurred after high-intensity focused ultrasound ablation in one patient with pancreatic cancer.
PubMedID- 24676133 Sex and age were not statistically significant predictors of post-operative survival time; however, tumor size, tumor stage, child classification, portal vein thrombosis and rs11077 snp site located in xpo5 3′utr were correlated with survival time in these patients (table 2).
PubMedID- 23275773 There was no evidence of portal vein thrombosis in any of these patients.
PubMedID- 25684014 portal vein thrombosis (pvt) is a common complication of end-stage liver disease with an incidence of 0.6-16% in patients with well-compensated disease, increasing up to 35% in cirrhotic patients with hepatocellular carcinoma.1 as recently as the 1990s, pvt was associated with an increased incidence of complications and a higher mortality rate.2 additionally, blood loss volumes in patients with complete thrombosis were reported to be significantly higher than those in patients without pvt or with partial pvt.3 nevertheless, the presence of pvt is no longer considered an absolute contraindication for liver transplantation, as many improvements have been made in surgical technique and perioperative management.2 in this report, we describe using polytetrafluoroethylene (ptfe) jump graft from the inferior mesenteric vein (imv) for portal inflow in a patient with severe portomesenteric venous thrombosis.
PubMedID- 25013563 portal vein thrombosis (pvt) is a complication of chronic liver disease, which occurs in approximately 5%–15% of the patients [1].
PubMedID- 26357616 A typical example of prehepatic portal hypertension is extrahepatic portal vein thrombosis, while a purely post-hepatic portal hypertension example is the budd–chiari syndrome (bcs) commonly due to membranous obstruction of the inferior vena cava.3–5 nevertheless, the main cause of biochemical liver abnormalities in patients with connective tissue diseases (ctd) is treatment with potentially hepatotoxic drugs or coexisting viral hepatitis.1 fibrotic autoimmune diseases are characterized pathogenetically by an inflammatory process that induces and sustains robust fibrosis.
PubMedID- 19937195 Sixteen patients were excluded from the study because of preoperative pve (n = 15) or partial portal vein thrombosis (n = 1) in the time period between hbs and ct volumetry.
PubMedID- 22066057 Microscopic portal vein thrombosis was identified in 8 cases (19.5%).
PubMedID- 24718401 portal vein thrombosis (pvt) is a complication of decompensated cirrhosis and is more likely to occur during late-stage liver cirrhosis1, with a prevalence of approximately 1 per cent in the general population2.
PubMedID- 25024946 [4] we describe a rare case of rapidly progressive community-acquired pala with portal vein thrombosis in a previously healthy child.
PubMedID- 21760875 Left branch portal vein thrombosis was reported in both cases.
PubMedID- 21769289 portal vein thrombosis resulted in high portal pressure and increased blood flow in an inferior mesenteric venous-inferior vena cava shunt, and hepatic encephalopathy with hyperammonemia was aggravated.
PubMedID- 24159391 One of the patients was detected to have portal vein thrombosis, and the other one was detected to have splenic vein thrombosis; therefore, portal vein and splenic vein diameters could not be measured in those patients, but those patients were diagnosed with portal hypertension.
PubMedID- 21507775 3a), new liver lesions, new portal vein thrombosis, metastatic lung nodules and metastatic adenopathy in the mesentery, retroperitoneum (fig.
PubMedID- 20492727 portal vein thrombosis (pvt) is a common complication in patients with advanced-stage hcc, occurring in 20%-80% of these patients [4-6].
PubMedID- PMC4472762 Patients with portal vein thrombosis had an increase in intem cft (p = 0.002, 95% ci (77.98, 317.97)) and maxvt (p = 0.03, 95% ci (5.53, 105.63)).
PubMedID- 25379558 Reported a case of portal vein thrombosis after splenectomy for hereditary stomatocytosis in a child [24], while skarsgard et al.

Page: 1 2